What is Luoxin Pharmaceuticals Group Stock Co., Ltd.'s (002793.SZ) StockRank?

MoatMap's StockRank for Luoxin Pharmaceuticals Group Stock Co., Ltd. (002793.SZ) is 31/100, with a Sell signal. This is a composite score combining Quality (40), Value (36), and Momentum (46) factor ranks across MoatMap's 20,000+ stock universe.

Does Luoxin Pharmaceuticals Group Stock Co., Ltd. have an economic moat?

Luoxin Pharmaceuticals Group Stock Co., Ltd. (002793.SZ) has a Quality factor score of 40/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Luoxin Pharmaceuticals Group Stock Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Luoxin Pharmaceuticals Group Stock Co., Ltd. (002793.SZ) is Sell, based on a StockRank of 31/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Luoxin Pharmaceuticals Group Stock Co., Ltd. in?

Luoxin Pharmaceuticals Group Stock Co., Ltd. (002793.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

002793.SZ

SELLREMOVE

Luoxin Pharmaceuticals Group Stock Co., Ltd. · Healthcare · China · $690M · Avg Vol: $14M/d

StockRank

P/E (TTM)

—

ROE

-19.5%

D/E

1.0x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Luoxin Pharmaceuticals is a Chinese pharmaceutical company. It lacks the global validation, scale, and high-utilization pricing power of the high-moat CDMOs we target in our biotech manufacturing theme.

COMPANY DESCRIPTION

Luoxin Pharmaceuticals Group Stock Co., Ltd. researches, manufactures, and sells pharmaceutical products, with a dominant position in digestive, respiratory, and anti-infective therapeutic areas. The company is a leading domestic manufacturer of proton pump inhibitors (PPIs) and other gastrointestinal treatments in China. It operates an integrated business model spanning innovative drug R&D, generic manufacturing, and an extensive hospital-focused sales network.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	530M	349M	391M	336M	-14.1%
EPS	-0.13	-0.09	-0.13	-0.04	—
Shares	1.1B	1.1B	1.1B	1.1B	0.0%
Debt	520M	221M	232M	155M	-33.2%
Equity	469M	365M	204M	172M	-28.4%
Op CF	-139M	69M	-23M	37M	-26.4%
Inv CF	-18M	142M	-197,350	18M	—
Fin CF	57M	-248M	-20M	-50M	—

PRICE (1M)-27.6%

SMA 50SMA 200

$0.60

RSI (14)

35.1

52W High

$1.00

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC

-16.5%30.1

ROE

-19.5%30.1

GP/Assets

33.0%70.0

Op. Margin

7.9%61.1

FCF/Assets

9.6%86.2

Piotroski

—28.7

Int. Cover

-4.2x31.0

D/E Ratio

1.04x14.3

Current Ratio

0.76x4.6

Value

P/E (TTM)

—N/A

EV/EBITDA

115.3x2.8

P/FCF

88.8x76.1

P/B

4.1x29.4

P/S

1.9x69.6

Div Yield

—N/A

Momentum

52W High %

60%40.5

RS 6M

-33%37.7

SMA 50/200

0.95x49.3

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

327%94.3

FUNDAMENTALS

Market Cap

$690M

P/E (Forward)

—

Gross Margin

51.6%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 002793.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
002793.SZ	Luoxin Pharmaceuticals Group Stock Co., Ltd.(you)	$690M	31	SELL
002728.SZ	Teyi Pharmaceutical Group Co.,Ltd	$671M	32	SELL
300158.SZ	Shanxi Zhendong Pharmaceutical Co.,Ltd	$738M	34	SELL
688247.SS	Sinotherapeutics Inc.	$571M	32	SELL
300485.SZ	Beijing Science Sun Pharmaceutical Co., Ltd.	$634M	27	SELL
002907.SZ	Chongqing Pharscin Pharmaceutical Co., Ltd.	$765M	26	SELL
688176.SS	Jiangsu Yahong Meditech Co., Ltd.	$961M	30	SELL
301277.SZ	Newland Pharmaceutical Co., Ltd.	$574M	34	SELL
002038.SZ	Beijing SL Pharmaceutical Co., Ltd.	$893M	28	SELL
002365.SZ	Qianjiang Yongan Pharmaceutical Co., Ltd.	$512M	28	SELL

Peer medians: ROE 4.8% · P/E 27.8x · Gross margin 53.1%

Luoxin Pharmaceuticals Group Stock Co., Ltd. (002793.SZ) — Stock Score Summary

Luoxin Pharmaceuticals Group Stock Co., Ltd. (002793.SZ) has a MoatMap StockRank of 31/100 based on Quality (40/100), Value (36/100), and Momentum (46/100) factor scores. The current signal is SELL. Luoxin Pharmaceuticals is a Chinese pharmaceutical company. It lacks the global validation, scale, and high-utilization pricing power of the high-moat CDMOs we target in our biotech manufacturing theme.

Key Financial Metrics

Price	$0.60
Market Cap	$690M
Price/Book	4.06
Return on Equity	-19.5%
Return on Invested Capital	-16.5%
Debt/Equity	104.42
Gross Margin	51.6%
Operating Margin	7.9%
Revenue Growth	20.7%
Free Cash Flow	$8M

Luoxin Pharmaceuticals Group Stock Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Luoxin Pharmaceuticals Group Stock Co., Ltd.’s (002793.SZ) StockRank?: MoatMap’s StockRank for Luoxin Pharmaceuticals Group Stock Co., Ltd. (002793.SZ) is 31/100, with a Sell signal. It is a composite of Quality (40), Value (36), and Momentum (46) factor ranks across MoatMap’s 20,000+ stock universe.
Does Luoxin Pharmaceuticals Group Stock Co., Ltd. have an economic moat?: Luoxin Pharmaceuticals Group Stock Co., Ltd. (002793.SZ) has a Quality factor score of 40/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Luoxin Pharmaceuticals Group Stock Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Luoxin Pharmaceuticals Group Stock Co., Ltd. (002793.SZ) is Sell, based on a StockRank of 31/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Luoxin Pharmaceuticals Group Stock Co., Ltd. in?: Luoxin Pharmaceuticals Group Stock Co., Ltd. (002793.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).